Immunoglobulin E (IgE): Understanding Your Blood Test Series

1. Overview: What this test reveals and why it is important

Immunoglobulin E (IgE) is an antibody class primarily involved in type I (immediate) hypersensitivity reactions and defence against parasitic infections. Total IgE measures the overall concentration of this antibody in blood, while specific IgE tests quantify reactivity to individual allergens. Elevated total IgE indicates an atopic predisposition (allergic asthma, eczema, rhinitis) or, in certain regions, helminthic infestation. Very high levels raise suspicion for rare conditions such as hyper‑IgE syndrome, allergic bronchopulmonary aspergillosis, or IgE myeloma. Low IgE is uncommon but may occur in some primary immunodeficiencies. The test does not identify what a person is allergic to—only that allergic propensity exists.

---

2. What does it measure

a. Units of measurement

· International units per millilitre (IU/mL) – most common

· Kilounits per litre (kU/L) – equivalent to IU/mL

· Micrograms per litre (µg/L) – some laboratories; 1 IU ≈ 2.4 µg

b. Normal Range (highly age‑dependent; reference intervals vary by laboratory)

· Birth – 1 year: 0 – 15 kU/L

· 1 – 5 years: 0 – 60 kU/L

· 6 – 9 years: 0 – 90 kU/L

· 10 – 15 years: 0 – 200 kU/L

· Adults: 0 – 100 kU/L (some labs extend to 150 kU/L)

Note: IgE levels are typically higher in children, peak in late childhood, and decline modestly in adulthood. Atopic individuals frequently exceed the normal range; conversely, a normal total IgE does not exclude allergy.

---

3. Other factors connected to this

a. Direct correlation (factors that directly raise total IgE)

· Atopic diseases – allergic asthma, atopic dermatitis, allergic rhinitis, conjunctivitis, food allergy.

· Parasitic infections – particularly helminths (roundworms, hookworms, schistosomiasis); IgE elevation is part of the protective immune response.

· Allergic bronchopulmonary aspergillosis (ABPA) – very high IgE (>1000 kU/L) in asthmatics or cystic fibrosis.

· Hyper‑IgE syndrome (Job syndrome) – genetic disorder with recurrent infections, eczema, and extreme IgE (>2000 kU/L).

· IgE myeloma – rare plasma cell dyscrasia.

· Certain primary immunodeficiencies – Omenn syndrome, Wiskott–Aldrich syndrome, some forms of combined immunodeficiency.

· Drug hypersensitivity reactions – e.g., anticonvulsants, certain antibiotics.

· Allergic bronchopulmonary mycosis – similar to ABPA but caused by other fungi.

· Tobacco smoking – modest elevation.

· Kawasaki disease – acute elevation reported.

b. Indirect correlation (factors that influence IgE independently or falsely)

· Ethnicity – Black and Hispanic individuals may have higher baseline IgE even without atopy.

· Seasonal variation – higher during pollen seasons in sensitised individuals.

· Age – levels peak in school‑age children, decline in elderly.

· Sex – males often have slightly higher IgE than females.

· Medications –

· Raise IgE: some antiepileptics (phenytoin, carbamazepine), interferons.

· Lower IgE: corticosteroids (transiently), omalizumab (monoclonal anti‑IgE, dramatically reduces free IgE), immunosuppressants.

· Haemolysis or lipaemia – may interfere with some immunoassays.

· Hook effect – extremely high IgE can saturate assay antibodies, causing falsely low readings; dilution required if hyper‑IgE syndrome suspected.

Important: Total IgE does not correlate perfectly with allergy severity; a patient may have severe allergic symptoms with normal total IgE, or elevated IgE without any identifiable allergic disease.

---

4. Disorders related to abnormal values

a. When elevated

· Allergic diseases –

· Atopic dermatitis (often highest among atopics)

· Allergic asthma

· Allergic rhinitis / sinusitis

· Food allergy

· Parasitic infestation – eosinophilia frequently co‑exists.

· Allergic bronchopulmonary aspergillosis (ABPA) – consider in asthmatics with infiltrates, central bronchiectasis, and IgE >1000 kU/L.

· Primary immunodeficiency syndromes –

· Hyper‑IgE syndrome (recurrent staphylococcal abscesses, pneumatoceles, coarse facies)

· Wiskott–Aldrich syndrome (eczema, thrombocytopenia, recurrent infections)

· Omenn syndrome (severe combined immunodeficiency with erythroderma, lymphadenopathy)

· IgE monoclonal gammopathy / myeloma – very rare.

· Certain vasculitides – Churg–Strauss syndrome (eosinophilic granulomatosis with polyangiitis) may show IgE elevation.

· Graft‑versus‑host disease – after bone marrow transplantation.

b. When low (undetectable or very low total IgE)

· Primary immunodeficiency –

· Common variable immunodeficiency (CVID)

· Selective IgM deficiency

· Ataxia‑telangiectasia

· IgG subclass deficiencies

· Acquired hypogammaglobulinaemia – e.g., secondary to B‑cell malignancies, protein‑losing enteropathy, immunosuppressive drugs.

· Genetic disorders – some rare defects in IgE class switching.

· Normal variant – approximately 2–5% of healthy individuals have undetectable IgE with no pathological consequence.

Clinical pearl: A very low total IgE in the context of recurrent sinopulmonary infections should prompt evaluation for humoral immunodeficiency.

---

5. Best way to address aberrant levels

Important principle: Total IgE is a biomarker, not a disease. Treatment is directed at the underlying condition—allergy, infection, immunodeficiency—not at the IgE number itself. Suppressing IgE without addressing the cause is rarely beneficial and may delay appropriate therapy. Omalizumab (anti‑IgE monoclonal antibody) is an exception; it is prescribed for specific indications (moderate‑to‑severe allergic asthma, chronic spontaneous urticaria) and reduces free IgE, but it is a specialised medical therapy, not a supplement.

a. Quick ways or using Medications

· Allergic diseases –

· Allergen avoidance – most effective and safest intervention; requires identification of triggers (skin prick testing, specific IgE).

· Antihistamines (cetirizine, loratadine, fexofenadine) – block histamine but do not lower IgE.

· Intranasal corticosteroids, inhaled corticosteroids – control mucosal inflammation; may modestly reduce total IgE over time.

· Leukotriene receptor antagonists (montelukast) – adjunctive.

· Omalizumab – recombinant humanised monoclonal anti‑IgE antibody; binds free IgE, prevents mast cell activation. Indicated for moderate‑severe allergic asthma inadequately controlled on inhaled steroids, and chronic spontaneous urticaria. Dramatically reduces free IgE within days, but total IgE measured by standard assays may appear increased because omalizumab‑IgE complexes are detected; interpret IgE levels on omalizumab with caution.

· Immunotherapy (allergy shots or sublingual tablets) – induces immunological tolerance; may cause long‑term reduction in IgE and blunting of seasonal rises.

· Parasitic infections – anthelmintic therapy (albendazole, ivermectin, praziquantel); IgE normalises weeks to months after successful eradication.

· ABPA – oral corticosteroids plus itraconazole or other antifungals; IgE decline parallels clinical improvement.

· Hyper‑IgE syndrome – prophylactic antibiotics, antifungals, and sometimes immunoglobulin replacement; haematopoietic stem cell transplantation in severe cases.

· IgE myeloma – chemotherapy directed at plasma cell dyscrasia.

Do not self‑prescribe immunosuppressants, biologics, or anthelmintics.

b. Using Supplements or Holistic medicine

· Omega‑3 fatty acids (EPA/DHA) – anti‑inflammatory; may attenuate allergic inflammation and reduce IgE in some studies.

· Preferred source: Algae oil – plant‑based, sustainable, free from ocean pollutants. Choose re‑esterified triglyceride form with documented EPA+DHA content (≥2 g/day combined).

· Avoid: Fish oil (ecological harm, overfishing, marine contaminants).

· Vitamin D – deficiency linked to increased allergic sensitisation and higher IgE.

· Supplement with D3 (cholecalciferol from lichen) , not D2. Target serum 25‑OH‑D >30 ng/mL.

· Quercetin – plant flavonoid; stabilises mast cells, inhibits histamine release, and may reduce IgE production in vitro.

· Sources: Naturally in onions, apples, berries, broccoli; supplementation often uses quercetin dihydrate or phytosome formulations for better absorption.

· Choose: Quercetin derived from Dimorphandra mollis (Brazilian tree) or other plant sources; avoid synthetic.

· Bromelain – proteolytic enzyme from pineapple stem; reduces nasal inflammation and may modulate allergic responses.

· Use standardised bromelain (≥2000 GDU/g); take between meals.

· Spirulina – blue‑green algae; studies suggest it can lower IgE and improve allergic rhinitis symptoms.

· Preferred: Organic spirulina (Arthrospira platensis) from controlled culture.

· Probiotics – certain strains (e.g., Lactobacillus rhamnosus, Bifidobacterium longum) may modulate immune system and reduce IgE in atopic children.

· Sources: Fermented plant foods (kimchi, sauerkraut, kombucha, water kefir) or high‑quality supplements with documented live cultures.

· Butterbur (Petasites hybridus) – herbal remedy for allergic rhinitis; some evidence comparable to antihistamines.

· Must use pyrrolizidine alkaloid‑free extracts (toxic to liver).

· Stinging nettle (Urtica dioica) – traditionally used for hay fever; limited but suggestive evidence.

· Ayurvedic approaches –

· Tinospora cordifolia (Guduchi) – immunomodulatory, may reduce IgE in allergic conditions.

· Albizia lebbeck (Shirisha) – traditionally used for asthma and allergies; some studies show IgE reduction.

· Withania somnifera (Ashwagandha) – adaptogen; may modulate Th2 responses.

· Always use standardised extracts; consult a qualified practitioner. Herbs can interact with antihistamines, corticosteroids, and immunosuppressants.

· Critical caution: Many allergy‑focused proprietary supplements contain synthetic folic acid or cyanocobalamin as cheap additives. If B vitamins are needed (e.g., in patients on methotrexate for atopic dermatitis), choose methylfolate and methylcobalamin.

c. Using Diet and Foods (following a plant‑forward, ecologically sustainable approach)

· General anti‑allergic dietary pattern –

· Mediterranean‑style, plant‑based diet – high intake of vegetables, fruits, legumes, whole grains, nuts, seeds, extra virgin olive oil.

· Low in ultra‑processed foods, refined sugars, trans fats – these promote systemic inflammation and may worsen allergic diathesis.

· Specific dietary components with potential IgE‑lowering or anti‑allergic effects:

· Polyphenol‑rich foods –

· Onions, apples, berries, citrus – high in quercetin.

· Green tea – EGCG inhibits IgE class switching in experimental models.

· Turmeric + black pepper – curcumin downregulates Th2 cytokines.

· Ginger – fresh or powdered; anti‑inflammatory.

· Omega‑3 plant sources (ALA) –

· Ground flaxseed, chia seeds, hemp seeds, walnuts.

· While ALA conversion to EPA/DHA is limited, these foods provide fibre and polyphenols that collectively reduce allergic inflammation.

· Dietary fibre –

· Legumes, oats, barley, vegetables, fruits – fermentable fibre produces short‑chain fatty acids (SCFA) that promote regulatory T cells and may suppress IgE.

· Target ≥40 g total fibre daily.

· Fungi –

· Shiitake, maitake, reishi – beta‑glucans and other polysaccharides exhibit immunomodulatory properties; limited human data in allergy but safe and ecologically sound.

· Reishi (Ganoderma lucidum) – traditionally used for asthma; some evidence of reduced IgE.

· Fermented plant foods –

· Kimchi, sauerkraut, kombucha, tempeh, miso – probiotic and postbiotic effects; may shift immune balance away from Th2 dominance.

· Algae –

· Spirulina, chlorella – whole food sources; some studies show reduced IgE and improved allergic rhinitis symptoms.

· Protein sources (hierarchy adhered) –

· Legumes (lentils, chickpeas, beans, tofu, tempeh) – primary protein base.

· Mycoprotein (Quorn) – sustainable fermentation product.

· Edible fungi – mushrooms.

· Lab‑grown / precision‑fermentation dairy proteins – acceptable emerging alternatives.

· Dairy / eggs – permitted but not emphasised; cow’s milk is itself a common allergen; elimination only if proven allergy.

· Meat, poultry, fish – deliberately omitted. Effective plant‑based, fungal, and fermentation‑derived alternatives exist for all anti‑allergic nutritional goals.

· Allergen‑specific dietary avoidance –

· Only eliminate foods that have been unequivocally proven to cause IgE‑mediated allergy (by specific IgE testing and/or oral food challenge).

· Indiscriminate elimination diets are unnecessary, socially restrictive, and can cause malnutrition.

· Foods to minimise –

· High‑advanced glycation end‑product (AGE) foods – grilled/broiled meats, fried foods – may promote inflammation.

· Industrial seed oils high in omega‑6 (soybean, corn, sunflower) – excess omega‑6 may skew toward pro‑inflammatory eicosanoids.

---

6. How soon can one expect improvement and the ideal time frame to retest

· Allergen avoidance – total IgE does not fall rapidly; it may take months to years to decline, and levels often remain above normal even after prolonged avoidance. Specific IgE to the avoided allergen may decrease more noticeably.

· Pharmacotherapy –

· Antihistamines, corticosteroids – do not significantly lower total IgE in routine use.

· Omalizumab – free IgE drops within 24–48 hours; total IgE (bound + free measured by standard assays) rises initially due to drug‑IgE complexes, then stabilises. Do not use total IgE to monitor omalizumab response; use clinical parameters.

· Immunotherapy – specific IgE may initially rise, then gradually decline over 1–3 years; total IgE may show modest reduction after several years.

· Anthelmintic therapy – IgE begins to fall 2–4 weeks after successful deworming; full normalisation may take 3–6 months.

· Dietary / supplement interventions –

· Algae oil omega‑3, vitamin D, quercetin, spirulina – modest effects on IgE, if any, are likely to require 3–6 months of consistent use.

· Retesting interval –

· For monitoring known allergic disease: annually unless clinical change warrants earlier assessment.

· After starting immunotherapy: specific IgE re‑checked at 1 year intervals.

· For suspected hyper‑IgE syndrome or ABPA: retesting guided by specialist.

· Do not repeat total IgE more often than every 3 months; it is a slowly changing parameter.

---

Conclusion

Total IgE is a valuable but non‑specific clue to the presence of atopy, parasitic infection, or certain rare immunological disorders. An elevated level should never be treated in isolation; the underlying diagnosis dictates management. For allergic diseases, allergen identification and avoidance, along with evidence‑based pharmacotherapy and immunotherapy, form the cornerstone of care. Adjunctive supplements such as algae‑sourced omega‑3, quercetin, and spirulina—chosen in bioavailable, ecologically responsible forms—may offer supportive anti‑allergic effects. A whole‑food, plant‑forward diet rich in fibre, polyphenols, and fermented foods aligns with both immune modulation and planetary health. As with all blood tests, the IgE result is a conversation starter, not a conclusion.

---x---x

Note on dietary recommendations on this site:

For the sake of our environment we adhere to the following dietary preference hierarchy:

1. Plant‑based

2. Fungi / algae / fermented

3. Biotechnology / lab‑grown / cultures

4. Dairy / eggs

5. Meat / fish / poultry (only if no effective alternative exists)

This approach reflects ecological responsibility, antibiotic stewardship, and the urgent need to reduce the environmental footprint of dietary recommendations.

-x-x